milk thistle and semaglutide 150 mg for Liver Support A new study conducted by

This supplement supports the body's natural GLP-1 production with herbal ingredients

This asset is highly complementary to our Phase 3 FSGS program and broadens our development footprint across the kidney disease continuum, from acute injury through to chronic disease." Dr Nina Webster, CEO & Managing Director, Dimerix Limited #Dimerix #KidneyDisease #RareDisease #Biopharma #DrugDevelopment #ClinicalTrials #Nephrology #PrecisionMedicine #HealthcareInnovation #Biotech To view or add a comment, sign in ICYMI: Early phase 1 data from Bambusa Therapeutics suggests #BBT001 delivered rapid, durable improvements in atopic dermatitis severity and itch, with sustained biomarker suppression, favorable safety, and the potential for dosing as infrequently as every 3 months

Reducing inflammation and protecting tissues: The elevated or chronic activation of NFB and MAPK signalling pathways is associated with inflammation and disease

Some patients report reduced carbohydrate cravings through inositols insulin sensitization